Zura Bio
Samantha Holt is an experienced professional in the biopharmaceutical sector, currently serving as a CMC Technical Project Manager at Zura Bio Limited since September 2023. Previously, Samantha held the position of Group Leader for the Research Cell Line and Exosome Production Team at Evox Therapeutics Ltd from March 2020 to September 2023. Prior roles include Associate Principal Scientist at Lonza, Senior Scientist at Allergan, and Upstream Process Science Scientist at Actavis Biologics Ltd. Samantha's career began at Leeds Teaching Hospitals NHS Trust, where work was conducted in the Biochemical Genetics Department. With a BSc (Hons) in Biology from Hull University, Samantha has a strong foundation in scientific research and development across various domains, including mammalian cell optimization and veterinary laboratories.
This person is not in any teams
This person is not in any offices
Zura Bio
1 followers
Zura Bio is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders. Currently, Zura Bio is developing three assets which have completed phase 1/1b studies and are Phase 2 ready. The company is developing a portfolio of therapeutic indications for tibulizumab (ZB-106), torudokimab (ZB-880), and ZB-168 with a goal of demonstrating their efficacy, safety, and dosing convenience in immune and inflammatory disorders. Zura Bio is headquartered in Henderson, NV with team members in the UK and USA.